Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1981 May 30;282(6278):1741–1744. doi: 10.1136/bmj.282.6278.1741

Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins.

N E Miller, F Hammett, S Saltissi, S Rao, H van Zeller, J Coltart, B Lewis
PMCID: PMC1505739  PMID: 6786600

Abstract

The relation of coronary artery disease to plasma lipoproteins was examined in 104 men aged 35-65 years undergoing coronary angiography for suspected myocardial ischaemia. A score reflecting the number, degree, and length of stenoses in seven major coronary arteries was assigned to each angiogram. Lipid concentrations in lipoprotein subfractions were measured after preparative ultracentrifugation; plasma apolipoprotein concentrations were measured by electroimmunoassay. Men with high coronary scores tended to have lower plasma high-density lipoprotein (HDL) cholesterol concentrations and higher low-density lipoprotein (density 1.019-1.063 g/ml) cholesterol concentrations than subjects of similar age with low coronary scores (p approximately equal to 0.1). The strongest relation, however, was with the cholesterol concentration in the HDL2 subfraction (density 1.063-1.125 g/ml) of HDL, which averaged 44% lower in the severely affected patients (p less than 0.005). No associations were found between the coronary score and HDL3 cholesterol, the cholesterol content of lipoproteins of density less than 1.019 g/ml, plasma triglyceride, or the concentrations of apolipoproteins AI, AII, and E. The high coronary scores associated with low HDL2 concentrations reflected an increase in the number of both partial and complete stenoses distributed throughout the coronary tree. In contrast the sizes of the lesions and the proportion producing complete occlusion were unrelated to HDL2.

Full text

PDF
1741

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albers J. J., Cheung M. C., Hazzard W. R. High-density lipoproteins in myocardial infarction survivors. Metabolism. 1978 Apr;27(4):479–485. doi: 10.1016/0026-0495(78)90102-6. [DOI] [PubMed] [Google Scholar]
  2. Albers J. J., Warnick G. R., Wiebe D., King P., Steiner P., Smith L., Breckenridge C., Chow A., Kuba K., Weidman S. Multi-laboratory comparison of three heparin-Mn2+ precipitation procedures for estimating cholesterol in high-density lipoprotein. Clin Chem. 1978 Jun;24(6):853–856. [PubMed] [Google Scholar]
  3. Avogaro P., Bon G. B., Cazzolato G., Quinci G. B. Are apolipoproteins better discriminators than lipids for atherosclerosis? Lancet. 1979 Apr 28;1(8122):901–903. doi: 10.1016/s0140-6736(79)91375-8. [DOI] [PubMed] [Google Scholar]
  4. Castelli W. P., Doyle J. T., Gordon T., Hames C. G., Hjortland M. C., Hulley S. B., Kagan A., Zukel W. J. HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. Circulation. 1977 May;55(5):767–772. doi: 10.1161/01.cir.55.5.767. [DOI] [PubMed] [Google Scholar]
  5. Fredrickson D. S., Levy R. I., Lees R. S. Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. N Engl J Med. 1967 Jan 5;276(1):34–contd. doi: 10.1056/NEJM196701052760107. [DOI] [PubMed] [Google Scholar]
  6. Gofman J. W., Young W., Tandy R. Ischemic heart disease, atherosclerosis, and longevity. Circulation. 1966 Oct;34(4):679–697. doi: 10.1161/01.cir.34.4.679. [DOI] [PubMed] [Google Scholar]
  7. Goldbourt U., Medalie J. H. High density lipoprotein cholesterol and incidence of coronary heart disease--the Israeli Ischemic Heart Disease Study. Am J Epidemiol. 1979 Mar;109(3):296–308. doi: 10.1093/oxfordjournals.aje.a112683. [DOI] [PubMed] [Google Scholar]
  8. Gordon T., Castelli W. P., Hjortland M. C., Kannel W. B., Dawber T. R. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med. 1977 May;62(5):707–714. doi: 10.1016/0002-9343(77)90874-9. [DOI] [PubMed] [Google Scholar]
  9. HAVEL R. J., EDER H. A., BRAGDON J. H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955 Sep;34(9):1345–1353. doi: 10.1172/JCI103182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hulley S. B., Rosenman R. H., Bawol R. D., Brand R. J. Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease. N Engl J Med. 1980 Jun 19;302(25):1383–1389. doi: 10.1056/NEJM198006193022503. [DOI] [PubMed] [Google Scholar]
  11. Ishikawa T., Fidge N., Thelle D. S., Førde O. H., Miller N. E. The Tromsø Heart Study: serum apolipoprotein AI concentration in relation to future coronary heart disease. Eur J Clin Invest. 1978 Jun;8(3):179–182. doi: 10.1111/j.1365-2362.1978.tb00832.x. [DOI] [PubMed] [Google Scholar]
  12. Janus E. D., Nicoll A., Wootton R., Turner P. R., Magill P. J., Lewis B. Quantitative studies of very low density lipoprotein: conversion to low density lipoprotein in normal controls and primary hyperlipidaemic states and the role of direct secretion of low density lipoprotein in heterozygous familial hypercholesterolaemia. Eur J Clin Invest. 1980 Apr;10(2 Pt 1):149–159. doi: 10.1111/j.1365-2362.1980.tb02075.x. [DOI] [PubMed] [Google Scholar]
  13. Jenkins P. J., Harper R. W., Nestel P. J. Severity of coronary atherosclerosis related to lipoprotein concentration. Br Med J. 1978 Aug 5;2(6134):388–391. doi: 10.1136/bmj.2.6134.388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Miller N. E., Thelle D. S., Forde O. H., Mjos O. D. The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study. Lancet. 1977 May 7;1(8019):965–968. doi: 10.1016/s0140-6736(77)92274-7. [DOI] [PubMed] [Google Scholar]
  15. Nichols A. V. Human serum lipoproteins and their interrelationships. Adv Biol Med Phys. 1967;11:109–158. doi: 10.1016/b978-1-4832-3107-5.50008-x. [DOI] [PubMed] [Google Scholar]
  16. Patsch J. R., Gotto A. M., Jr, Olivercrona T., Eisenberg S. Formation of high density lipoprotein2-like particles during lipolysis of very low density lipoproteins in vitro. Proc Natl Acad Sci U S A. 1978 Sep;75(9):4519–4523. doi: 10.1073/pnas.75.9.4519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Pearson T. A., Bulkley B. H., Achuff S. C., Kwiterovich P. O., Gordis L. The association of low levels of HDL cholesterol and arteriographically defined coronary artery disease. Am J Epidemiol. 1979 Mar;109(3):285–295. doi: 10.1093/oxfordjournals.aje.a112682. [DOI] [PubMed] [Google Scholar]
  18. Tan M. H., Macintosh W., Weldon K. L., Kapoor A., Chandler B. M., Hindmarsh T. J. Serum high density lipoprotein cholesterol in patients with abnormal coronary arteries. Atherosclerosis. 1980 Oct;37(2):187–198. doi: 10.1016/0021-9150(80)90004-0. [DOI] [PubMed] [Google Scholar]
  19. Weisgraber K. H., Mahley R. W. Subfractionation of human high density lipoproteins by heparin-Sepharose affinity chromatography. J Lipid Res. 1980 Mar;21(3):316–325. [PubMed] [Google Scholar]
  20. Zilversmit D. B. Atherogenesis: a postprandial phenomenon. Circulation. 1979 Sep;60(3):473–485. doi: 10.1161/01.cir.60.3.473. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES